当前位置: 首页 > 期刊 > 《中国中医药图书情报》 > 20174
编号:13609342
国际高影响因子期刊收录中草药论文分析(5)
http://www.100md.com 2017年8月1日 《中国中医药图书情报》 20174
     [3] 曾強.2000-2009年SCI收录期刊刊载的我国中医药高校论文的情况分析[J].中华医学图书情报杂志,2011,20(12):71-76.

    [4] FUGH-BERMAN A. Herb-drug interactions[J]. Lancet, 2000,355(9198):134-138.

    [5] NORTIER JL, MARTINEZ MC, SCHMEISER HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)[J]. New England Journal of Medicine, 2000,342(23):1686-1692.

    [6] HOESSEL R, LECLERC S, ENDICOTT JA, et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases[J]. Nature Cell Biology, 1999,1(1): 60-67.

    [7] KONG WJ, WEI J, ABIDI P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins[J]. Nature Medicine, 2004,10(12):1344-1351.

    [8] 刘则渊,王贤文,陈超美.科学知识图谱方法及其在科技情报中的应用[J].数字图书馆论坛,2009(10):14-34.

    [9] GRAHAM IA, BESSER K, BLUMER S, et al. The genetic map of Artemisia annua L. identifies loci affecting yield of the antimalarial drug artemisinin[J]. Science, 2010,327(5963): 328-331.

    [10] WANG J, ZHANG CJ, CHIA WN, et al. Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum[J]. Nature Communications, 2015(6):10111., 百拇医药(刘菊红)
上一页1 2 3 4 5